Alopecia areata (AA) is an immunological disorder characterised by hair loss. Individuals with AA report high levels of social anxiety. One intervention that holds potential for reducing social anxiety in individuals with AA is mindfulness-based cognitive therapy (MBCT).

Our key aim was to investigate whether MBCT reduces social anxiety in individuals with AA. The study also investigated whether MBCT reduces depression, general anxiety, and increases quality of life and increases trait mindfulness in individuals with AA.

Five participants with AA took part in an 8-session in-person MBCT intervention. A multiple-baseline single-group case series design was adopted. Idiographic measures of social anxiety were measured each day from baseline, through intervention, to follow-up. Standardised questionnaires of trait mindfulness, social anxiety, depression, anxiety, and quality of life were completed at baseline, post-intervention, and at 4-week follow-up.

All participants completed the MBCT course, but one participant was excluded from the idiographic analysis due to a high amount of missing data. The remaining four participants demonstrated reductions in idiographic measures of social anxiety from baseline to follow-up. These effects were larger between baseline and follow-up, than between baseline and post-intervention. Two participants demonstrated significant improvement in standardised measures of wellbeing from baseline to follow-up – they also practised mindfulness most regularly at home between sessions.

MBCT may be effective in reducing social anxiety and improving wellbeing in individuals with AA, although this might be dependent on the extent to which participants regularly practise mindfulness exercises.

Adjustment disorder (AD) is described as a maladaptive reaction to an identifiable psychosocial stressor/s that usually emerges within a month after the onset of the stressor. With all uncertainty, fears and disorientation, it’s no surprise that many people have developed an AD linked to the sudden changes brought about by COVID-19, such as threat to life, imposed restrictions, and the associated changes. Mindfulness-based cognitive therapy (MBCT) has been found to be effective for depression and anxiety problems, little is known, however, about its efficacy for adjustment disorder.

The aim of the current research was to evaluate if 4 weeks long, modified internet-delivered MBCT can reduce symptoms of Covid-19 related AD.

438 individuals with a diagnosis of AD were recruited to take part in the study. They were randomly assigned to i-MBCT, i-progressive muscle relaxation training (i-PMR), and Waiting List (WL). Assessments with questionnaires evaluating AD (ADMN-20), depression (PHQ-9, HADS-D), and anxiety (HADS-A, GAD-7) were filled at baseline, 4-week, and 1-month post-randomization. 142 individuals completed baseline and 4 week assessment (i-MBCT, n= 34; i-PMR, n= 36 and WL, n=72).

We found a significant reduction in AD symptoms following the i-MBCT group, whereas no change was found in both control conditions. While a decrease in depressive and anxiety was found in both i-MBCT and i-PMR groups, the greatest reduction has been observed in i-MBCT.

These preliminary findings suggest that i-MBCT can be an effective intervention in treating Covid-19 related AD, but more studies are needed.

No significant relationships.

Nous ne constatons aucune différence significative entre le groupe contrôle et le groupe consolidation MBCT en termes de âge de début de troubles (25 ± 11 vs 27 ± 10), de nombre de TS, d’hospitalisations (2 ± 4 vs 2 ± 2), ou de nombre d’épisodes maniaques (6 ± 7 vs 7 ± 8) et dépressifs (12 ± 12 vs 13 ± 16).

Après avoir décrit les modalités de ce groupe, nous évaluerons le profil des patients qui y participent (âge moyen de 48 ans ± 10) au regard de la régularité et de l’assiduité en termes de participation et de présence. Nous présenterons l’évolution des compétences de pleine conscience acquises et développées en lien avec leur assiduité et à l’instauration de leur pratique de méditation à la fois formelle et informelle.

BMI, EDI-2, EAT, BDI-13, BITE, STAI Ya/Yb, le Ruminative Response Scale for Eating Disorder (RRSED), l’Acceptance and Action Questionnaire-II (AAQ-II), le Five Facets Mindfulness Questionnaire (FFMQ), le Mindfulness Attention Awareness Scale (MAAS), le Kentucky Inventory of Mindfulness Skills (KIMS), le Body Shape Questionnaire (BSQ), l’Impulsive Behavior Scale : Urgency, Premeditation, Perseverance, and Sensation Seeking (UPPS), le Cambridge Exeter Repetitive Thinking Scale (CERTS) et le Three Factor Eating Questionnaire (TFEQ). Nous présenterons les résultats préliminaires de cette recherche ainsi que le projet de suite de ce travail de recherche clinique.

Facilitating mindfulness programmes within an inpatient mental health setting is discussed. The difficulty in effectively engaging patients at this acute stage in their illness is focussed upon. Other challenges discussed are identifying appropriate inclusion and exclusion criteria; identifying the optimal programme format for this setting; promoting mindfulness within the environment of the inpatient unit and the training requirements for programme facilitators. The article concludes that due attention should be given to these challenges in order to maintain the integrity of mindfulness as an effective intervention for mental health difficulties.

The aim of this study is to examine the efficacy of mindfulness-based cognitive therapy (MBCT) in addition to treatment as usual (TAU) for recurrent depressive patients with and without a current depressive episode.

A randomized, controlled trial comparing MBCT+TAU (n=102) with TAU alone (n=103). The study population consisted of patients with three or more previous depressive episodes. Primary outcome measure was post-treatment depressive symptoms according to the Hamilton Rating Scale for Depression. Secondary outcome measures included the Beck Depression Inventory, rumination, worry and mindfulness skills. Group comparisons were carried out with linear mixed modelling, controlling for intra-group correlations. Additional mediation analyses were performed. Comparisons were made between patients with and without a current depressive episode.

Patients in the MBCT+TAU group reported less depressive symptoms, worry and rumination and increased levels of mindfulness skills compared with patients receiving TAU alone. MBCT resulted in a comparable reduction of depressive symptoms for patients with and without a current depressive episode. Additional analyses suggest that the reduction of depressive symptoms was mediated by decreased levels of rumination and worry.

The study findings suggest that MBCT is as effective for patients with recurrent depression who are currently depressed as for patients who are in remission. Directions towards a better understanding of the mechanisms of action of MBCT are given, although future research is needed to support these hypotheses.